These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33625583)

  • 1. Huntington's disease: lessons from prion disorders.
    Alpaugh M; Cicchetti F
    J Neurol; 2021 Sep; 268(9):3493-3504. PubMed ID: 33625583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
    Hernaiz A; Toivonen JM; Bolea R; Martín-Burriel I
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of prion-like transfer in Huntington's disease models.
    Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-like proteins and their computational identification in proteomes.
    Batlle C; Iglesias V; Navarro S; Ventura S
    Expert Rev Proteomics; 2017 Apr; 14(4):335-350. PubMed ID: 28271922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
    Pearce MMP; Kopito RR
    Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance.
    Alpaugh M; Denis HL; Cicchetti F
    Mol Psychiatry; 2022 Jan; 27(1):269-280. PubMed ID: 34711942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
    Pineau H; Sim V
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
    Hope J; Kirby L
    Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of autophagy in prion protein-induced neurodegenerative diseases.
    Yao H; Zhao D; Khan SH; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):494-502. PubMed ID: 23459558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein and prion disease at a glance.
    Zhu C; Aguzzi A
    J Cell Sci; 2021 Sep; 134(17):. PubMed ID: 34472604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of prion-induced toxicity.
    Mercer RCC; Harris DA
    Cell Tissue Res; 2023 Apr; 392(1):81-96. PubMed ID: 36070155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insoluble TATA-binding protein accumulation in Huntington's disease cortex.
    van Roon-Mom WM; Reid SJ; Jones AL; MacDonald ME; Faull RL; Snell RG
    Brain Res Mol Brain Res; 2002 Dec; 109(1-2):1-10. PubMed ID: 12531510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.